Lyons Market Valuation

Is 531441 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 531441 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 531441's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 531441's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 531441?

Key metric: As 531441 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 531441. This is calculated by dividing 531441's market cap by their current revenue.
What is 531441's PS Ratio?
PS Ratio	27.1x
Sales	₹3.30m
Market Cap	₹89.35m

531441 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	n/a
Enterprise Value/EBITDA	n/a
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does 531441's PS Ratio compare to its peers?

The above table shows the PS ratio for 531441 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	16.2x
539669 RGF Capital Markets	34.5x	n/a	₹106.5m
506365 Chemo Pharma Laboratories	6.4x	n/a	₹119.9m
531341 Ashtasidhhi Industries	9.6x	n/a	₹133.7m
538897 Shri Niwas Leasing & Finance	14.1x	n/a	₹84.6m
531441 Lyons Market	27.1x	n/a	₹89.3m

Price-To-Sales vs Peers: 531441 is expensive based on its Price-To-Sales Ratio (27.1x) compared to the peer average (16.2x).

Price to Sales Ratio vs Industry

How does 531441's PS Ratio compare vs other companies in the IN Diversified Financial Industry?

19 Companies	Price / Sales	Estimated Growth	Market Cap
ABCAPITAL Aditya Birla Capital	1.7x	16.0%	US$5.91b
AGSTRA AGS Transact Technologies	0.7x	n/a	US$115.67m
530499 A. K. Capital Services	1.6x	n/a	US$96.67m
530585 Swastika Investmart	1.9x	n/a	US$30.46m

19 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: 531441 is expensive based on its Price-To-Sales Ratio (27.1x) compared to the Indian Diversified Financial industry average (9.7x).

Price to Sales Ratio vs Fair Ratio

What is 531441's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

531441 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	27.1x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 531441's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Manappuram Finance

₹127.1b

A gold loan non-banking financial company, provides retail credit products and financial services in India.

531213

₹155.45

0.4%

2.6%

Aditya Birla Capital

₹496.3b

Through its subsidiaries, provides various financial products and services in India and internationally.

ABCAPITAL

₹191.24

3.5%

12.4%

Aditya Birla Capital

₹496.3b

Through its subsidiaries, provides various financial products and services in India and internationally.

540691

₹191.25

3.6%

12.4%